𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of remission with l-asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia

✍ Scribed by G. Gahrton; L. Engstedt; S. Franzén; B. Gullbring; G. Holm; S. Höglund; A. Killander; D. Killander; D. Lockner; H. Mellstedt; J. Palmblad; P. Reizenstein; K-O. Skarberg; B. Swedberg; A-M. Udén

Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
650 KB
Volume
34
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short courses of cytosine arabinoside an
Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia
✍ H. Ekert; J. H. Colebatch; R. N. Matthews 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

Courses of cytosine arabinoside followed by L-asparaginase were administered for 4 days each to 17 children with previously treated acute lymphatic leukemia, at 14to 27-day intervals. Complete or partial remission occurred in 81% of patients after the third or fourth course of therapy. Rlaintenance

L-asparaginase used with cytosine arabin
L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone
✍ Smithson, William A. ;Gilchrist, Gerald S. ;Burgert, E. Omer 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with L‐asparaginase and cytosine arabinoside (1‐β‐D‐arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1

Use of L-asparaginase and cytosine arabi
Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia
✍ Steuber, C. Philip ;Levy, Gary J. ;Nix, William L. ;Shepherd, Dell A. ;Starling, 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

## Abstract Ten patients with late‐stage acute lymphocytic leukemia were treated with L‐asparaginase and cytosine arabinoside. Complete remission was achieved in 8 patients including 5 of 5 patients with T‐cell leukemia. Major toxicity included anaphylactic reactions in 3 of the 10 patients.

Remission induction in acute nonlymphocy
Remission induction in acute nonlymphocytic leukemia: Comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin
✍ Preisler, H. ;Bjornsson, S. ;Henderson, E. S. ;Hryniuk, W. ;Higby, D. ;Freeman, 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

Forty-six previously untreated patients with acute nonlymphocytic leukemia were treated with a remission induction regimen consisting of three daily doses of Adriamycin (30 mg/m2/day) and a ten-day continuous infusion of cytosine arabinoside (ara C) (100 mg/m2/day). The overall remission rate was 72

Management of adult patients with acute
Management of adult patients with acute lymphoblastic leukemia in first complete remission : Systematic review and meta-analysis
✍ Ron Ram; Anat Gafter-Gvili; Liat Vidal; Mical Paul; Isaac Ben-Bassat; Ofer Shpil 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB

## Abstract ## BACKGROUND: The optimal postremission therapy in adults with acute lymphoblastic leukemia (ALL) is still a matter of debate. The objective of this study was to compare the various potential therapeutic options for patients who achieved first complete remission. ## METHODS: The aut